Magic8BallResponse Posted - 6 days ago

$DSGN Hold your nose....

Magic8BallResponse Posted - 6 days ago

$DSGN Wake me up in a year....

vu_jade Posted - 1 week ago

$DSGN chart improving

Doozio Posted - 1 week ago

$DSGN INTA 🧠⏰♾️

Magic8BallResponse Posted - 1 week ago

$DSGN Exited.... way to slow... back in 2025

ChessGM Posted - 2 weeks ago

$DSGN "eads up alert! Upcoming earnings on Monday, 11/11/2024 for $DSGN Neutral (5.0) In the current assessment of Design Therapeutics (NASDAQ: DSGN), there are mixed sentiments surrounding the company's financial health and market positioning. On one hand, the company is navigating through a cash-intensive phase typical for biotech firms, and while it has not yet achieved profitability, its management appears confident in effectively utilizing its available cash resources. This is a crucial factor as it indicates a potential for strategic investments and development within their pipeline. On the other hand, recent insider purchases suggest a degree of confidence among management, which can be interpreted as a positive signal for investors. However, the overall financial metrics present a cautious outlook; the company may be trading at a higher P/E ratio compared to industry standards, reflecting investor optimism that may not yet be matched by tangible results in earnings or revenue growth. Quantitatively, it is essential to analyze key performance indicators such as earnings per share (EPS) and revenue forecasts. Currently, DSGN has an EPS that indicates negative growth, typical for firms in the development stage. Revenue forecasts remain modest, as analysts predict slow growth in the upcoming quarters. Comparisons with industry peers reveal that while DSGN is positioned in a promising sector, its valuation might be inflated given its current financial performance compared to more established companies within the biotech realm. Looking ahead, the anticipation surrounding upcoming earnings reports is notable. Analysts are expecting the company to maintain its trajectory of investment in research and development, despite reporting losses. Historical performance has shown volatility, but the consensus estimates suggest a narrowing of losses, which could be seen as a positive development. The potential impact of these earnings on stock performance could either reinforce the bullish sentiment stemming from insider buying or exacerbate bearish concerns if results fall short of expectations. Thus, investor sentiment may hinge on the forthcoming earnings report, making the analysis of DSGN's performance crucial in determining future stock movements. - Funds were net buyers of $DSGN during the previous reporting quarter. - Top 5 funds with large holdings in $DSGN: * Logos Global Management LP $17MM. New position. CGMFundRank: 58% * Baker Brothers Advisors LP $6MM. New position. CGMFundRank: 75%, Fund Website: www.edgr.io * Tang Capital Management LLC $5MM. New position. CGMFundRank: 51% * Point72 Asset Management LP $3MM. New position. CGMFundRank: 86%, Fund Website: www.point72.com * D. E. Shaw & Co $2MM. New position. CGMFundRank: 85% - Last 10 days performance: 7% - Last 30 days performance: 21% - Last 90 days performance: 40% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.

Magic8BallResponse Posted - 2 weeks ago

$DSGN Can we get a 7 please!

Magic8BallResponse Posted - 2 weeks ago

$DSGN BOOM! $TIL

Magic8BallResponse Posted - 2 weeks ago

$DSGN WAKE THE .... UP

Sunny_24 Posted - 1 month ago

$DSGN

Magic8BallResponse Posted - 1 month ago

$TIL $BNTX $AUTL $CABA $DSGN

Magic8BallResponse Posted - 09/23/24

$DSGN Hoping new formulation has what it takes to get some restoration of Frataxin

Magic8BallResponse Posted - 09/23/24

$DSGN Meaningful treatment for patients.... everyone should be praying this works....

AnomalyDetective Posted - 09/22/24

Prior MDA breakout stocks $COMM $CRVS $EVLV $DSGN still going strong from selection with all new picks released Friday for members in advance of Week 39. Watch for the next signals and daily selections here: http://vmbreakouts.com Or join our great investor community with more portfolios and live chat rooms here: https://seekingalpha.com/marketplace/1201-value-momentum-breakouts/subscribe

Magic8BallResponse Posted - 2 months ago

$DSGN How about that quad stack now!

Magic8BallResponse Posted - 2 months ago

$DSGN Patients need this one... If they can get muscle concentration similar to plasma this is a gem!

Magic8BallResponse Posted - 2 months ago

$DSGN Would be amazing for patients. Can they really get this to work?

Magic8BallResponse Posted - 2 months ago

$TIL $SMMT $BNTX $DSGN (DSGN a patient focused play)

Magic8BallResponse Posted - 2 months ago

$TIL $SMMT $AUTL $CABA $DSGN

Avocado_smash Posted - 2 months ago

$DSGN

Avocado_smash Posted - 2 months ago

$DSGN bull chart continue today

shared_alerts Posted - 2 months ago

-09/11/2024- 📉 SCANNER UPDATE📈 $ALT $ALLO $DSGN $MARA ↩️

WycklyTrades Posted - 2 months ago

$DSGN $GME $PLUG >>> Tech 3x ETF: TECL & TECS 'potential' trend reversal setups. $AMC > $DOGE.X

itzroly Posted - 2 months ago

$BLMZ $LASE $DSGN $BKYI fun day scalp shorting these stocks with a lot of price action and volume. New opportunities tomorrow

Sunny_24 Posted - 2 months ago

$HOTH $DSGN

Magic8BallResponse Posted - 2 months ago

$DSGN Would love to see this work. Huge unmet need

tradingtwenty Posted - 2 months ago

$DSGN has trended 16 times in the past 24 hours (based on 5 minute intervals). Latest press release on Sep 10, 2024 08:00 AM: Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference Link: https://tradingtwenty.com/news/617820/design-therapeutics-to-participate-in-the-2024-cantor-global-healthcare-conference

Avocado_smash Posted - 2 months ago

$DSGN

Magic8BallResponse Posted - 2 months ago

$DSGN Added

topstockalerts Posted - 2 months ago

$DSGN $5.90 must hold or risk downside